Home » Topics » BioWorld Science

BioWorld Science
RSS

China's NMPA approves IND for B7H4x4-1BB bispecific antibody HBM-7008

June 9, 2022

OnCusp licenses ex-China rights to Multitude's CDH6 antibody-drug conjugate

June 9, 2022

Qualigen Therapeutics initiates IND-enabling studies for QN-302

June 9, 2022

FDA clears Passage Bio's IND for PBML-04 for metachromatic leukodystrophy

June 9, 2022

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

June 9, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

June 9, 2022

Platelet-activating factor receptor antagonists discovered at Boehringer Ingelheim

June 9, 2022

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

June 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...